Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mirati Therapeutics (NQ: MRTX ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Jan 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mirati Therapeutics < Previous 1 2 3 4 5 6 7 8 9 Next > Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 December 29, 2023 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023. Via Benzinga EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday December 20, 2023 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga Analyst Expectations For Mirati Therapeutics's Future December 20, 2023 Via Benzinga Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment November 29, 2023 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:EXEL),(NASDAQ:MRTX),(NYSE:LLY),(NASDAQ:PNT) EQNX::TICKER_END Via FinancialNewsMedia Topics Death Exposures Death What 11 Analyst Ratings Have To Say About Mirati Therapeutics November 07, 2023 Via Benzinga 3 Resilient Stocks with Massive Potential to Boost Your Wealth November 26, 2023 These three stocks with massive potential can make patient investors fabuslously wealthy as they come roaring back to life. Via InvestorPlace These Three Biotech Stocks Are Trading At A Discount November 23, 2023 Investors exposed to the biotech sector have seen mixed results this year. Via Talk Markets 10 Health Care Stocks With Whale Alerts In Today's Session November 17, 2023 Via Benzinga 3 Biotech Stocks That Could Boom or Bust by 2025 November 16, 2023 Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday. Via InvestorPlace MIRATI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mirati Therapeutics, Inc. - MRTX November 08, 2023 From Kahn Swick & Foti, LLC Via Business Wire 3 No-Brainer Stocks to Buy With $500 Right Now November 08, 2023 A reasonably modest amount of money can go a long way when it's invested in time-tested businesses with sustained catalysts. Via The Motley Fool Appian To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Tuesday November 07, 2023 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Via Benzinga Is MIRATI THERAPEUTICS INC Ready to Break Out of Its Range? November 06, 2023 Investors are keeping a close eye on MIRATI THERAPEUTICS INC (NASDAQ:MRTX) as it boasts an impressive technical rating of 7 out of 10, signaling a possible breakout. Via Chartmill 7 Healthcare Stocks That Can Cure a Lackluster Portfolio October 19, 2023 Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio. Via InvestorPlace Opdivo's Subcutaneous Formulation Shows Promise in Advanced Kidney Cancer: Bristol Myers Squibb's Latest Findings October 19, 2023 Bristol Myers Squibb Co (NYSE: BMY) released topline data from the Phase 3 CheckMate -67T noninferiority trial of a subcutaneous Opdivo (nivolumab) compared to intravenous (IV) Opdivo for advanced or... Via Benzinga Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race October 17, 2023 Major pharmaceutical companies are continuing to make substantial acquisitions in the field of oncology, sparking enthusiasm in the market. Bristol Myers Squibb (NYSE:BMY) just announced its plan to... Via PressReach BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq – CNSL), Mirati Therapeutics, Inc.® (Nasdaq - MRTX), Pioneer Natural Resources (NYSE - PXD), Summit Materials (NYSE October 16, 2023 From Brodsky & Smith LLC Via GlobeNewswire Amgen Stock Surges To 10-Month High, Up 4% On An Unexpected Upgrade October 11, 2023 The company has growing pipeline optionality, according to the upgrade report. Via Investor's Business Daily Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023 October 10, 2023 Via Benzinga Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race October 10, 2023 Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant... Via PressReach MIRATI THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mirati Therapeutics, Inc. - MRTX October 09, 2023 From Kahn Swick & Foti, LLC Via Business Wire 10 Health Care Stocks Whale Activity In Today's Session October 09, 2023 Via Benzinga Why Shares of Tango Therapeutics Are Dropping Monday October 09, 2023 Another company's buyout helped drive up the price last week. This week, investors started out by selling the stock. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023 October 09, 2023 Via Benzinga Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session October 09, 2023 Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near... Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mirati Therapeutics, Inc.® (Nasdaq - MRTX), LiveVox Holdings, Inc. (Nasdaq - LVOX), SP® Plus Corporation (Nasdaq - SP), Summit Materials (NYSE - SUM) October 09, 2023 From Brodsky & Smith LLC Via GlobeNewswire Mirati Therapeutics Snags $5.8 Billion Takeover Deal, But Shares Fall On Lowball Bid October 09, 2023 Bristol Myers Squibb hopes to buy Mirati Therapeutics for up to $5.8 billion. Via Investor's Business Daily Bristol Myers Squibb Strengthens Oncology Portfolio With Mirati Therapeutics' $5B Deal October 09, 2023 Bristol Myers Squibb & Co (NYSE: BMY) has agreed to acquire Mirati Therapeutics Inc (NASDAQ: MRTX) for $58.00 per share in cash, for a total Via Benzinga S&P 500, Nasdaq Set For Bleak Start To Week As Middle East Tensions Dampen Risk-On Mood: Earnings, Inflation Data In Focus October 09, 2023 Trading in stock futures suggests a lower open on Monday as traders digest the ramification of the conflict in the Middle East. Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Tesla, Mirati Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session October 09, 2023 U.S. stock futures traded lower this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.